chr17-42536480-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3

The NM_000263.4(NAGLU):​c.208G>C​(p.Gly70Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 1,214,376 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. G70G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

NAGLU
NM_000263.4 missense

Scores

4
8
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 3.50

Publications

0 publications found
Variant links:
Genes affected
NAGLU (HGNC:7632): (N-acetyl-alpha-glucosaminidase) This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate. [provided by RefSeq, Jul 2008]
NAGLU Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 3B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet, Myriad Women’s Health
  • Charcot-Marie-Tooth disease axonal type 2V
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.827

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NAGLUNM_000263.4 linkc.208G>C p.Gly70Arg missense_variant Exon 1 of 6 ENST00000225927.7 NP_000254.2
NAGLUXM_024450771.2 linkc.208G>C p.Gly70Arg missense_variant Exon 1 of 7 XP_024306539.1
NAGLUXM_047436138.1 linkc.-254G>C 5_prime_UTR_variant Exon 1 of 5 XP_047292094.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NAGLUENST00000225927.7 linkc.208G>C p.Gly70Arg missense_variant Exon 1 of 6 1 NM_000263.4 ENSP00000225927.1
NAGLUENST00000586516.5 linkc.-44G>C upstream_gene_variant 2 ENSP00000467135.1
NAGLUENST00000591587.1 linkc.-50G>C upstream_gene_variant 5 ENSP00000467836.1
ENSG00000266929ENST00000585572.1 linkn.-30G>C upstream_gene_variant 4

Frequencies

GnomAD3 genomes
AF:
0.0000133
AC:
2
AN:
149992
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000298
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000132
AC:
14
AN:
1064384
Hom.:
0
Cov.:
30
AF XY:
0.0000137
AC XY:
7
AN XY:
510232
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
21288
American (AMR)
AF:
0.00
AC:
0
AN:
7960
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13374
East Asian (EAS)
AF:
0.00
AC:
0
AN:
21400
South Asian (SAS)
AF:
0.00
AC:
0
AN:
24666
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
20244
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2866
European-Non Finnish (NFE)
AF:
0.0000143
AC:
13
AN:
911388
Other (OTH)
AF:
0.0000243
AC:
1
AN:
41198
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000133
AC:
2
AN:
149992
Hom.:
0
Cov.:
33
AF XY:
0.0000137
AC XY:
1
AN XY:
73144
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41204
American (AMR)
AF:
0.00
AC:
0
AN:
15074
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3436
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9816
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000298
AC:
2
AN:
67168
Other (OTH)
AF:
0.00
AC:
0
AN:
2066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 16, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: NAGLU c.208G>C (p.Gly70Arg) results in a non-conservative amino acid change located in the Alpha-N-acetylglucosaminidase, N-terminal (IPR024240) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 13176 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.208G>C has been reported in the literature in an individual affected with Mucopolysaccharidosis (Pollard_2013). These report(s) do not provide unequivocal conclusions about association of the variant with Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome B). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 22976768). ClinVar contains an entry for this variant (Variation ID: 557699). Based on the evidence outlined above, the variant was classified as uncertain significance.

Mucopolysaccharidosis, MPS-III-B Uncertain:1
Apr 10, 2018
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.050
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.74
D
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.54
T
M_CAP
Pathogenic
0.98
D
MetaRNN
Pathogenic
0.83
D
MetaSVM
Uncertain
0.19
D
MutationAssessor
Benign
1.5
L
PhyloP100
3.5
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-0.33
N
REVEL
Uncertain
0.36
Sift
Benign
0.53
T
Sift4G
Benign
0.53
T
Vest4
0.47
ClinPred
0.94
D
GERP RS
4.4
PromoterAI
0.0044
Neutral
Varity_R
0.49
gMVP
0.51
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1329159364; hg19: chr17-40688498; API